MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

Search

Cytek Biosciences Inc

Cerrado

SectorSalud

3.71 -0.54

Resumen

Variación precio

24h

Actual

Mínimo

3.65

Máximo

3.73

Métricas clave

By Trading Economics

Ingresos

8.7M

9.6M

Ventas

-18M

34M

BPA

0.116

Margen de beneficio

28.655

Empleados

648

EBITDA

-5.5M

-2.5M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+92.18% upside

Dividendos

By Dow Jones

Próximas Ganancias

7 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-159M

514M

Apertura anterior

4.25

Cierre anterior

3.71

Noticias sobre sentimiento de mercado

By Acuity

60%

40%

335 / 386 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bearish Evidence

Cytek Biosciences Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

4 abr 2025, 22:38 UTC

Acciones populares

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

5 abr 2025, 09:30 UTC

Ganancias

Elon Musk's Mr. Fix-It Takes Center Stage During a Really Bad Week -- WSJ

5 abr 2025, 01:00 UTC

Adquisiciones, fusiones, absorciones

How BlackRock's Larry Fink Won Over Donald Trump -- WSJ

5 abr 2025, 01:00 UTC

Adquisiciones, fusiones, absorciones

How BlackRock's Larry Fink Won Over Donald Trump -- WSJ -2-

4 abr 2025, 21:53 UTC

Charlas de Mercado

Maxeon's Supply Chain Move at Critical Time for Solar Panel Cos -- Market Talk

4 abr 2025, 21:44 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Trump Grants 75-Day Extension to Reach TikTok Deal -- 3rd Update

4 abr 2025, 21:00 UTC

Principales Noticias

Americans Were Souring on Trump's Economic Plans Even Before Tariff Bloodbath -- WSJ

4 abr 2025, 20:52 UTC

Charlas de Mercado

Peloton Likely to Escape Tariffs Unscathed -- Market Talk

4 abr 2025, 20:52 UTC

Principales Noticias

Trump Can Cut Teacher-Training Programs For Now, Supreme Court Says -- WSJ

4 abr 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

4 abr 2025, 20:48 UTC

Principales Noticias

The Score: Nike, Apple, Stellantis and More Stocks That Defined the Week -- WSJ

4 abr 2025, 20:45 UTC

Principales Noticias

Hiring Defied Expectations in March, With 228,000 New Jobs -- 6th Update

4 abr 2025, 20:32 UTC

Principales Noticias

Dow Tumbles 2,000 Points, Bonds Rally After China Retaliates Against Trump Tariffs -- WSJ

4 abr 2025, 20:21 UTC

Principales Noticias

China Hits Back at Trump With Sweeping Tariffs on All U.S. Goods -- Update

4 abr 2025, 20:00 UTC

Principales Noticias

Republicans March Ahead on Trump's Tax Cuts as Tariffs Kick In -- WSJ

4 abr 2025, 19:51 UTC

Charlas de Mercado

Dollar Recovers While Recession Fears Grip Wall Street -- Market Talk

4 abr 2025, 19:37 UTC

Principales Noticias

Trump's Team is Getting the Bond Rally It Wanted. But for the Wrong Reasons. -- WSJ

4 abr 2025, 19:32 UTC

Charlas de Mercado

Oil Selloff Continues as China Responds to U.S. Tariffs -- Market Talk

4 abr 2025, 19:28 UTC

Principales Noticias

U.S. Stocks Fall Further After China Retaliates Against Trump Tariffs -- Update

4 abr 2025, 19:15 UTC

Charlas de Mercado

Costco Gold, Membership Fees Could Help Cushion from Tariff Costs -- Market Talk

4 abr 2025, 19:12 UTC

Principales Noticias

Powell Warns of Higher Prices, Weaker Growth After Tariff Plan -- 3rd Update

4 abr 2025, 19:11 UTC

Charlas de Mercado

U.S. Natural Gas Falls as Global Selloff Continues -- Market Talk

4 abr 2025, 19:09 UTC

Charlas de Mercado

Mexican Stocks, Peso Tumble as Global Rout Continues -- Market Talk

4 abr 2025, 19:09 UTC

Principales Noticias

Trump Grants 75-Day Extension to Reach TikTok Deal -- Second Update

4 abr 2025, 19:00 UTC

Charlas de Mercado

Fed Has Limited Options to Counter Tariffs -- Market Talk

4 abr 2025, 18:53 UTC

Charlas de Mercado

Brace for Trump's Tariff Order to Remain in Place for Extended Period -- Market Talk

4 abr 2025, 18:51 UTC

Charlas de Mercado

Morgan Stanley Analysts Outline Paths to Recession -- Market Talk

4 abr 2025, 18:44 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

4 abr 2025, 18:44 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

4 abr 2025, 18:44 UTC

Charlas de Mercado

Tariffs Won't Achieve What Trump Wants, Morgan Stanley Says -- Market Talk

Comparación entre iguales

Cambio de precio

Cytek Biosciences Inc Esperado

Precio Objetivo

By TipRanks

92.18% repunte

Estimación a 12 meses

Media 7.13 USD  92.18%

Máximo 9 USD

Mínimo 4.5 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Cytek Biosciences Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

4 ratings

2

Comprar

1

Mantener

1

Vender

Puntuación técnica

By Trading Central

3.71 / 3.9Soporte y Resistencia

Corto Plazo

Weak Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Strong Bearish Evidence

Sentimiento

By Acuity

335 / 386 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.